Table 3.
Characteristic | β | P Value |
---|---|---|
Age | 0.03 | .306 |
Men | −0.06 | .053 |
Body mass index | −0.02 | .572 |
Current smokers | 0.03 | .321 |
Dyslipidemia | 0.10 | .001 |
Diabetes mellitus | 0.04 | .163 |
eGFR | −0.01 | .720 |
Hyperuricemia | −0.02 | .526 |
History of cardiovascular disease | 0.10 | .002 |
No. of antihypertensive drugs | 0.13 | <.001 |
Antihypertensive medications | ||
CCB | <0.001 | .994 |
ACE inhibitor | −0.20 | <.001 |
ARB | 0.13 | <.001 |
β‐Blocker | 0.12 | <.001 |
α‐Blocker | <0.001 | .992 |
Diuretic | 0.15 | <.001 |
Timing of antihypertensive medications | ||
After breakfast | 0.21 | <.001 |
After dinner | −0.13 | <.001 |
Time after bathing ≤120 min | −0.25 | <.001 |
Drinking | −0.10 | .002 |
Abbreviations: ACE, angiotensin‐converting enzyme; ARB, angiotensin II receptor blocker; B‐D, at‐bedtime systolic home blood pressure value minus the before‐dinner systolic home blood pressure value; CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate.